Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Athenex, Inc. - Common Stock (NQ: ATNX )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, May 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Athenex, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Dow Jumps 150 Points; Crude Oil Rises 1%
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 150 points on Tuesday. 
Via Benzinga
Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 296% to $3.71 after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who... 
Via Benzinga
Looking Into Athenex's Return On Capital Employed
Via Benzinga
TSLA Stock Price Predictions: Where Will Elon Musk’s Tesla Go Next?
Tesla (TSLA) stock price predictions continue to be a concern among investors following Elon Musk's acquisition of Twitter in October. 
Via InvestorPlace
Dogecoin Price Predictions: Where Will DOGE Go After Overtaking Coinbase?
Dogecoin (DOGE) price predictions are a hot topic among crypto traders on Tuesday as they react to the value of Coinbase (COIN). 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Is Athenex (ATNX) Stock Up 44% Today?
Athenex (ATNX) stock is rocketing higher on Tuesday thanks to positive results from a high-risk early-stage breast cancer clinical trial. 
Via InvestorPlace
Nasdaq Edges Lower; Gold Rises 1.5%
U.S. stocks traded mixed midway through trading, with the S&P 500 and the Nasdaq Composite moving lower on Tuesday. 
Via Benzinga
Athenex Announces Quantum Leap Healthcare Collaborative Reports Positive Trial Result of I-SPY2 Trial for Oral Paclitaxel in Combination with PD-1 and Carboplatin in Neoadjuvant Breast Cancer
Oral Paclitaxel combination regimen has graduated in this Phase 2 trial in the triple negative breast cancer subgroup 
From Athenex, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Athenex Exits 503B Sterile Compounding Business
Full-year 2022 product sales guidance maintained at 20-25% growth year-over-year 
From Athenex, Inc.
Via GlobeNewswire
Why Okta Shares Are Trading Higher By Around 14%; Here Are 27 Stocks Moving Premarket
Gainers Pacifico Acquisition Corp. (NASDAQ: PAFO) shares rose 40.9% to $7.58 in pre-market trading after dipping around 43% on Wednesday. 
Via Benzinga
Athenex Announces Positive Results of Special Stockholder Meeting
From Athenex, Inc.
Via GlobeNewswire
AiViva's Diverse Product Pipeline Could Have The Potential To Transform Unmet Medical Needs
AiViva BioPharma is a clinical-stage biotech company developing innovative and transformative treatments and products to address unmet medical needs for a wide array of diseases.  
Via Benzinga
Athenex Announces Closing of the Sale of its China API Business
From Athenex, Inc.
Via GlobeNewswire
Athenex to Participate in the 5th Annual Evercore ISI HealthCONx Conference
From Athenex, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Cidara Therapeutics (NASDAQ:CDTX) shares rose 14.6% to $0.64 during Monday's pre-market session. The market value of their outstanding shares is at $44.9 million. The company's, Q3 earnings... 
Via Benzinga
Athenex: Q3 Earnings Insights
Athenex (NASDAQ:ATNX) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Athenex beat estimated earnings by... 
Via Benzinga
Athenex Announces Receipt of Positive Nasdaq Listing Determination
Nasdaq Hearing Panel grants continued listing of Athenex and extension to regain compliance with the minimum bid price requirement 
From Athenex, Inc.
Via GlobeNewswire
Athenex Provides Third Quarter 2022 Financial Results and Business Update
From Athenex, Inc.
Via GlobeNewswire
Athenex to Provide Corporate and Financial Update for the Third Quarter 2022 on November 3, 2022
From Athenex, Inc.
Via GlobeNewswire
Athenex Files Definitive Proxy Statement for Special Stockholder Meeting
From Athenex, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Pulmatrix (NASDAQ:PULM) shares rose 11.9% to $4.3 during Wednesday's after-market session. The company's market cap stands at $14.5 million. 
Via Benzinga
Nasdaq Turns Lower; Crude Oil Rises Sharply
U.S. stocks pared gains toward the end of trading, with the Nasdaq Composite turning lower on Thursday. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
  
Via Benzinga
Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday
Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported worse-than-expected Q2 EPS and sales results. 
Via Benzinga
Why Matterport Is Trading Higher By Around 25%, Here Are 73 Stocks Moving In Thursday's Mid-Day Session
Gainers Timber Pharmaceuticals, Inc. (NYSE: TMBR) shares rose 63.8% to $0.1769. Timber Pharmaceuticals recently announced closing of $8.0 million public offering. 
Via Benzinga
Here's Why Athenex Stock Is Getting Obliterated Thursday
Athenex Inc (NASDAQ: ATNX) shares are trading lower by 45.95% to $0.60 Thursday morning after the company announced a public offering valued at approximately $30 million. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
  
Via Benzinga
Why Is Disney Higher By More Than 7%: Here Are 40 Stocks Moving Premarket
Gainers 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.